• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail
-

GRN No. 535

Beta-glucanase from Streptomyces violaceoruber

Intended Use: For use as a processing aid in the production of yeast extracts and alcoholic beverages.
Basis: Scientific Procedures
Notifier: Nagase America Corporation
Notifier Address: 546 5th Avenue 16th Floor, New York, NY 10036
Date of filing: Aug 18, 2014
GRAS Notice (releasable information): GRN 535 (in PDF) (873 kB)
Date of closure: Feb 3, 2015
FDA's Letter: FDA has no questions

2362  

-
-